• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有心脏受累并导致心源性休克的套细胞白血病的管理。

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock.

作者信息

Furqan Muhammad, Chen Yamei, Akinleye Akintunde, Sarungbam Judy, Gass Alan, Seiter Karen, Liu Delong

机构信息

Division of Hematology and Oncology, Department of Medicine, Westchester Medical Center, 100 Woods Rd, Valhalla, NY, 10595, USA.

出版信息

Front Med. 2014 Jun;8(2):254-8. doi: 10.1007/s11684-014-0319-1. Epub 2014 Mar 14.

DOI:10.1007/s11684-014-0319-1
PMID:24627286
Abstract

Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term "mantle cell lymphoma" in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

摘要

套细胞淋巴瘤是B细胞非霍奇金淋巴瘤的一种侵袭性亚型。它可进展至白血病期,但初诊时出现典型白血病表现并不常见。白血病期提示疾病处于晚期,通常与广泛的结外受累相关。心包侵犯已有报道,然而自1992年“套细胞淋巴瘤”这一术语被定义以来,我们尚未发现有该疾病心肌浸润的报道。在此,我们报告一例套细胞白血病累及心脏导致心源性休克的病例,这使治疗决策变得复杂。

相似文献

1
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock.伴有心脏受累并导致心源性休克的套细胞白血病的管理。
Front Med. 2014 Jun;8(2):254-8. doi: 10.1007/s11684-014-0319-1. Epub 2014 Mar 14.
2
From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.来自MD安德森癌症中心档案:未经治疗的白血病性非结外型套细胞淋巴瘤,21年后复发为多形性变异型套细胞淋巴瘤
Ann Diagn Pathol. 2021 Feb;50:151649. doi: 10.1016/j.anndiagpath.2020.151649. Epub 2020 Oct 24.
3
Intraocular involvement of Mantle cell lymphoma: A case report and literature review.眼内套细胞淋巴瘤:病例报告及文献复习。
Hematol Oncol Stem Cell Ther. 2021 Jun;14(2):147-152. doi: 10.1016/j.hemonc.2019.03.002. Epub 2019 Apr 6.
4
Extensive colorectal lymphomatous polyposis complicated by acute intestinal obstruction: a case report.广泛的结直肠淋巴瘤性息肉病并发急性肠梗阻:一例报告
J Med Case Rep. 2017 Jul 13;11(1):190. doi: 10.1186/s13256-017-1340-1.
5
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma.无症状白血病性非淋巴结套细胞淋巴瘤并发弥散性血管内凝血的病例
Ann Hematol. 2024 Aug;103(8):3273-3275. doi: 10.1007/s00277-024-05727-7. Epub 2024 Apr 3.
6
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.惰性套细胞白血病:一种以孤立性淋巴细胞增多、骨髓间质浸润、κ 轻链限制性表达为特征的临床病理变异型,具有良好的预后。
Haematologica. 2011 Aug;96(8):1121-7. doi: 10.3324/haematol.2010.036277. Epub 2011 Apr 20.
7
Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia.利妥昔单抗对一名患有非典型CD20(++)骨髓套细胞淋巴瘤并导致严重全血细胞减少的患者产生显著反应。
Ann Hematol. 2004 May;83(5):316-8. doi: 10.1007/s00277-003-0793-z. Epub 2003 Nov 13.
8
Cutaneous manifestations of mantle cell lymphoma: an extensive literature review.套细胞淋巴瘤的皮肤表现:一项全面的文献综述
Acta Dermatovenerol Alp Pannonica Adriat. 2020 Dec;29(4):185-191.
9
Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen.伴有脾脏孤立性白血病性非结节性套细胞淋巴瘤的尼曼-匹克病
Blood. 2020 Mar 5;135(10):778. doi: 10.1182/blood.2019003479.
10
Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.通过结膜鲑鱼粉红色病变活检诊断的套细胞淋巴瘤。
J Clin Exp Hematop. 2014;54(2):143-7. doi: 10.3960/jslrt.54.143.

引用本文的文献

1
Mantle Cell Lymphoma With Cardiac Involvement Presenting as Complete Heart Block.表现为完全性心脏传导阻滞的合并心脏受累的套细胞淋巴瘤。
JACC Case Rep. 2024 Aug 7;29(15):102416. doi: 10.1016/j.jaccas.2024.102416.
2
Autopsy case of cardiac mantle cell lymphoma presenting with recurrent pulmonary tumor embolism after chemotherapy.尸检病例:化疗后反复发生肺肿瘤栓塞的心脏套细胞淋巴瘤。
J Clin Exp Hematop. 2024 Sep 28;64(3):242-251. doi: 10.3960/jslrt.24024. Epub 2024 Jul 31.

本文引用的文献

1
Ibrutinib and novel BTK inhibitors in clinical development.伊布替尼和处于临床开发阶段的新型 BTK 抑制剂。
J Hematol Oncol. 2013 Aug 19;6:59. doi: 10.1186/1756-8722-6-59.
2
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.伊布替尼治疗复发慢性淋巴细胞白血病的 BTK 靶点。
N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19.
3
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.伊布替尼治疗复发或难治性套细胞淋巴瘤中的 BTK。
N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19.
4
Novel agents and biomarkers for acute lymphoid leukemia.新型药物和生物标志物在急性淋巴细胞白血病中的应用
J Hematol Oncol. 2013 Jun 18;6:40. doi: 10.1186/1756-8722-6-40.
5
Novel agents for chronic lymphocytic leukemia.新型慢性淋巴细胞白血病药物。
J Hematol Oncol. 2013 May 16;6:36. doi: 10.1186/1756-8722-6-36.
6
MEK and the inhibitors: from bench to bedside.MEK 抑制剂:从实验室到临床。
J Hematol Oncol. 2013 Apr 12;6:27. doi: 10.1186/1756-8722-6-27.
7
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.苯达莫司汀联合利妥昔单抗与 CHOP 联合利妥昔单抗作为惰性和套细胞淋巴瘤患者一线治疗的比较:一项开放标签、多中心、随机、3 期非劣效性临床试验。
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.
8
First-line treatment of indolent lymphoma: axing CHOP?惰性淋巴瘤的一线治疗:摒弃CHOP方案?
Lancet. 2013 Apr 6;381(9873):1163-5. doi: 10.1016/S0140-6736(12)61965-5. Epub 2013 Feb 20.
9
Using primary site as a predictor of survival in mantle cell lymphoma.以原发部位作为套细胞淋巴瘤患者生存预测指标。
Cancer. 2013 Apr 15;119(8):1570-7. doi: 10.1002/cncr.27898. Epub 2013 Jan 22.
10
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.CD19:B 细胞发育、淋巴瘤诊断和治疗的生物标志物。
Exp Hematol Oncol. 2012 Nov 29;1(1):36. doi: 10.1186/2162-3619-1-36.